Jenny Yang On The BioHub by Avetix

Apr 9, 2026

In this episode, Jenny Yang, Founder and CEO of Outpost Bio, a company building an AI-driven platform to understand how the human microbiome interacts with drugs, food, and other interventions.

Outpost Bio Co-Founder and CEO Jenny Yang joined the podcast to talk about why the microbiome remains an underexplored layer in drug discovery—and how advances in AI and biological data generation are making it possible to model its interactions with drugs, food, and other interventions.

The conversation covers:

Why the microbiome is an important but historically difficult variable to account for in drug discovery and personalized health
How advances in AI are making it possible to model increasingly complex biological systems
Why high-quality, purpose-built biological data is critical for building models that translate beyond the lab
Jenny’s path from machine learning and genomics research at Oxford and Exscientia to founding Outpost Bio

The conversation covers:

Why the microbiome is an important but historically difficult variable to account for in drug discovery and personalized health
How advances in AI are making it possible to model increasingly complex biological systems
Why high-quality, purpose-built biological data is critical for building models that translate beyond the lab
Jenny’s path from machine learning and genomics research at Oxford and Exscientia to founding Outpost Bio

News

Jul 17, 2026

An AI-Powered Approach Decodes Gut Microbiome Interactions

Outpost Bio leverages machine learning to develop models that can identify interactions among stool microbes to improve drug development. Written by Shelby Bradford, PhD and published in The Scientist.

News

Jul 17, 2026

An AI-Powered Approach Decodes Gut Microbiome Interactions

Podcast

Feb 12, 2026

Beyond the Clinic: Innovation in Healthcare

Dr. Jenny Yang, CEO and Co-Founder of Outpost Bio, shares how AI is unlocking the microbiome’s potential to transform drug development. From overcoming the biggest barriers in the field to translating insights into real-world impact, Jenny explains the science, strategy, and vision behind Outpost Bio, plus her hot take on where the industry is heading.

Podcast

Feb 12, 2026

Beyond the Clinic: Innovation in Healthcare

Blog

Mar 29, 2026

Can Transformers Learn the Language of the Microbiome?

Drugs that you take interact with a complex microbial ecosystem in your gut. Trillions of microorganisms call the human digestive tract home and interact with one another and with their human host. This microbial world can directly modify drug structure (1–4), influence host immune responses (5,6), and alter pharmacokinetics (4,7). Currently, most drug development programs choose to ignore the gut microbiome because a reliable method to predict how it impacts drugs does not exist.